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Abstract
Dietary non-digestible carbohydrates (NDC) are perceived to improve health via gut 
microbiota-dependent generation of products such as short-chain fatty acids (SCFA). 
In addition, SCFA are also precursors for lipid and cholesterol synthesis potentially 
resulting in unwanted effects on lipid metabolism. Inulin is a widely used model 
prebiotic dietary fiber. Inconsistent reports on the effects of inulin on cholesterol 
homeostasis have emerged in humans and preclinical models. To clarify this issue, 
the present study aimed to provide an in-depth characterization of the effects of 
short-chain (sc)- and long-chain (lc)- inulin on cholesterol synthesis, absorption and 
elimination in mice. Feeding wildtype C57BL/6J mice diets supplemented with 
10% (w/w) of either sc- or lc-inulin for two weeks resulted in approximately 2.5-fold 
higher fecal SCFA levels (P<0.01) compared with controls, but had no significant 
effects on plasma and liver lipids. Subtle shifts in fecal and plasma bile acid species 
were detected with beta-muricholic acid increasing significantly in plasma of the 
inulin fed groups (1.7-fold, P<0.05). However, neither sc-inulin nor lc-inulin affected 
intestinal cholesterol absorption, mass fecal cholesterol excretion or trans-intestinal 
cholesterol excretion (TICE). Combined, our data demonstrate that sc- and lc-inulin 
have no adverse effects on cholesterol metabolism in mice despite increased generation 
of SCFA.




Inulin is a soluble non-digestible carbohydrate studied for its health benefits such 
as improved bowel movements, lowering blood glucose levels and potential lipid 
modulating effects.1–4 Inulin is naturally available in many types of plants. As 
ingredient for the food industry native inulin is mainly extracted from chicory roots.5 
Structurally, inulin is composed of β-2,1-linked fructans with a terminal glucose. The 
chain length varies, in other words, there is a varying degree of polymerization (DP), 
which on average ranges between 2-60.6,7 The β-2,1-linked fructose units present in 
all types of inulin prevent it from digestion by mammalian hydrolytic enzymes in 
the intestine.8 
As a result, inulin undergoes fermentation by the microbiota in different parts of 
the intestine resulting in the production of short-chain fatty acids (SCFA).9 Recently, 
several studies showed that SCFA could potentially regulate metabolic pathways in the 
liver as well as other organs and thereby exert physiological health effects.10–12 However, 
gut-derived SCFA such as acetate, for example, can potentially serve as a precursor for 
cholesterol and fatty acid synthesis.13 Thereby, inulin might exert adverse effects on 
metabolism by increasing plasma cholesterol levels and thus the risk for atherosclerotic 
cardiovascular disease. Previous studies in animal models as well as human trials have 
been ambiguous in terms of cholesterol modulating properties of inulin. Oligofructose 
and inulin have been shown to lower plasma cholesterol in apolipoprotein E-deficient 
mice.14 However, the effects were not evident in germ-free rats inoculated with human 
fecal microflora nor in obese Zucker rats.15,16 While in healthy humans cholesterol levels 
remained unchanged with inulin consumption, dyslipidemic patients consuming inulin 
for a longer duration had lower cholesterol levels.17–20
In the present study we aimed to elucidate in detail the effects of inulin on 
cholesterol absorption and elimination. We performed an in vivo dietary intervention 
study in mice using either short-chain enriched (sc-) or long-chain (lc-) enriched inulin. 
Our data demonstrate that, despite a substantially increased intestinal production 
of SCFA, inulin has no adverse effects on de novo cholesterol synthesis, intestinal 
cholesterol absorption or cholesterol elimination pathways.
Materials and Methods
Experimental animals
Nine weeks old conventional male C57BL/6 mice were obtained from Harlan 
(Horst, The Netherlands) and were housed in a temperature controlled room with 
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alternating 12 h light-dark cycles. All animal experiments were approved by the 
Committee of Animal Experimentation at the University of Groningen and performed 
in accordance with the Dutch national Law on Animal Experimentation (Wod) as 
well as international guidelines on animal experimentation. Three different diets 
were randomly assigned to mice and provided ad libitum for a period of 14 days in a 
parallel design. Baseline diet (supplied by Safe Diets, Augy, France) contained 60.94% 
corn starch, 0.06% cholesterol, 20% caseinate, 0.3% L-cystine, 7% carbohydrate mix 
(sucrose:maltodextrin, 50:50), 7% soya bean oil, 0.2% choline bitartrate, 3.5% mineral 
mixture (AIN 93 M/G), 1% vitamin mixture (w/w, AIN 93 M/G). A modified diet 
contained 10% lc-inulin (Frutafit® TEX!, DP of 10-60, Sensus, The Netherlands) or 
sc-inulin (Frutafit® CLR, DP of 2-40, Sensus, The Netherlands) replacing an equal 
amount of corn starch (50.94% corn starch, 0.06% cholesterol, 20% caseinate, 0.3% 
L-cystine, 7% carbohydrate mix, 7% soya bean oil, 0.2% choline bitartrate, 3.5% 
mineral mixture, 1% vitamin mixture). 
Bile collection and analysis of bile acid, 
cholesterol and phospholipid excretion.
The gallbladder was cannulated under anaesthesia (hypnorm 1 ml/kg body weight; 
diazepam 10 mg/kg body weight). Bile was collected for 20 minutes and the secretion 
rates were determined gravimetrically. Lipid extraction from bile was performed 
according to the general procedure of Bligh and Dyer with minor modifications.32 
Cholesterol was measured with colorimetric assays (Roche Diagnostic, Basel, 
Switzerland). Phospholipids were determined by measuring phosphate as described, 
bile acid profiles were generated using liquid chromatography tandem MS (LC-MS/
MS) as published previously.33 Secretion of bile acids, cholesterol and phospholipids 
was calculated by measuring the respective concentrations and multiplying with bile 
secretion rates.
Plasma lipid and lipoprotein analysis
At the time of sacrifice blood was collected by heart puncture using EDTA as 
anti-coagulant. Plasma was obtained and aliquots were stored at -80oC until further 
analysis. Commercially available colorimetric assays were used to measure plasma 
total cholesterol and triglycerides (Roche Diagnostic, Basel, Switzerland). Plasma bile 
acid concentrations in each mouse were measured using LC-MS/MS as described.33 
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Analysis of hepatic lipid composition
At the time of sacrifice, the liver was collected and homogenized in PBS. Lipids were 
extracted from the homogenates according to the general procedure of Bligh and Dyer 
with minor modifications and redissolved in water containing 2% Triton X-100.32 
Total cholesterol and triglyceride content was measured using commercially available 
kits (Roche Diagnostics). 
Fecal neutral sterols, bile acids and SCFA analysis
Mice were housed individually and fecal samples were collected at the end of the dietary 
intervention over a period of 24 h. Fecal samples of each mouse were dried, weighed 
and ground. Neutral sterols and bile acids were extracted and their concentrations 
were measured using gas liquid chromatography.32 SCFA (acetic acid, propionic 
acid and butyric acid) and other organic acids (succinic acid and lactic acid) were 
quantified based on a method published previously with some modifications.34 The 
acids were extracted by mixing thoroughly 50 mg fecal samples into 0.35 ml of 50 mM 
sulfuric acid and 0.025 ml of 4 mg/ml 2-ethylbutyric acid (internal standard). After 
centrifugation at 18,600 g and 4 oC for 20 minutes, the supernatant was analyzed 
by high performance liquid chromatography coupled to a refractive index detector 
(HPLC-RI) as described in literature. 34
Cholesterol absorption studies and calculation of TICE
Fractional cholesterol absorption was measured with an adapted plasma dual isotope 
ratio method using blood samples obtained after intravenous (D7) and oral (D5) 
administration of stable isotopically labelled cholesterol as described before.35 
Trans-intestinal cholesterol efflux (TICE) is calculated according to the following 
formula: TICE = fecal cholesterol excretion – [% intestinal cholesterol absorption × 
(biliary cholesterol secretion + dietary cholesterol intake)].
Real-time PCR for hepatic gene expression analysis
Using TriReagent (Sigma) total mRNA was extracted from the liver and quantified 
with a Nanodrop ND-100UV-vis spectrophotometer (NanoDrop Technologies 
Wilmington DE). cDNA was synthesized using 1µg of total RNA and reagents 
from Invitrogen (Carlsbad CA). Real-time PCR was performed on an ABI Prism 
7700 system (Applied Biosystems, Darmstadt Germany). Primers were synthesized 
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by Eurogentec (Seraing, Belgium). For each gene, mRNA expression was calculated 
relative to the housekeeping gene cyclophilin. 
Statistics
Statistical analysis was performed using GraphPad Prism software (San Diego, 
CA). All data are presented as median (interquartile range). Statistically significant 
differences between groups were determined using one-way ANOVA and Turkey test 
for post-hoc analysis. P-values below 0.05 were considered statistically significant.
Results
Sc-and lc- inulin increase the intestinal production of SCFA 
Two weeks of dietary intervention with sc- or lc-inulin did not change body weight 
compared to mice fed control diet (data not shown). Sc-inulin significantly increased 
fecal acetic (2-fold), propionic (2-fold) and butyric acid (4-fold) levels (each P<0.01, 
Figs. 1A, 1B and 1C). On the other hand, lc-inulin increased acetic (2-fold, P<0.05), 
propionic (2-fold, P<0.05) and succinic acid (9-fold, P<0.01) production (Figs. 1A, 
1B and 1D), while butyric acid production was comparable to the control group. 
Overall, considerable shifts were observed in terms of the ratio (Ac:Pr:Bu:Su) of SCFA 
generated in sc-inulin (51:29:15:6) and lc-inulin (50:26:9:15) fed groups compared to 
mice fed control diet (61:25:10:4).







Figure 1: Sc- and lc- inulin increase fecal short-chain fatty acid content. (A) acetic 
acid; (B) propionic acid; (C) butyric acid; (D) succinic acid. Following two-weeks 
administration of the respective diets, feces were collected over a period of 24h. Fecal 
samples from each mouse were used for extraction and analysis of SCFA. Data are 
presented as box plots showing median (interquartile range) and min/max; at least n=6 
for each group; ns, not significant. Statistically significant differences are indicated as 
*P<0.05; **P<0.01.
Impact of sc- and lc- inulin on cholesterol metabolism
At the end of the dietary intervention, plasma cholesterol and triglyceride levels were 
not different among the experimental groups (Figs. 2A and 2B), as were hepatic 
cholesterol and triglyceride contents (Figs. 2C and 2D). Hepatic mRNA expression of 
cholesterol synthesis-related genes such as Hmgcr remained unchanged in all groups 
(Figs. 3).
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Figure 2: Sc- and lc- inulin have no effect on plasma and hepatic lipid levels. 
(A)  plasma total cholesterol (TC); (B) plasma triglycerides (TG); (C) hepatic TC 
and (D) hepatic TG. At the time of sacrifice plasma samples were collected from the 
experimental mice for total cholesterol and triglyceride measurements. Livers were 
excised, weighed and stored at -80oC for later lipid analysis. Data are presented as box 
plots showing median (interquartile range) and min/max; at least n=6 for each group. 
Neither sc- nor lc-inulin had significant effects on biliary cholesterol secretion and 
fecal neutral sterol excretion (Figs. 4A and 4B). Fractional cholesterol absorption upon 
sc- or lc-inulin feeding was similar to that in controls (Fig. 4C). Based on these data 
we also calculated excretion of cholesterol through the TICE pathway. The data show 
that in inulin fed mice TICE remained comparable to controls (Fig. 4D). 




Figure 3: Hepatic gene expression in mice fed sc- and lc-inulin. At day 14 livers were 
excised and stored at -80oC for later analysis. Quantitative real-time PCR was carried 
out as described in methods. Individual genes are expressed as a ratio to the expression 
of the housekeeping gene cyclophilin. Data are presented as box plots showing median 
(interquartile range) and min/max; at least n=6 for each group. Statistically significant 
differences are indicated as *P<0.05. 
Sc- and lc-inulin induce subtle shifts in 
biliary and fecal bile acid composition
Prebiotics can impact the composition of the intestinal microbiota potentially resulting 
in altered bile acid profiles.21 Our analyses indicate that total bile acids in bile remained 
comparable in all groups (Fig. 5A), while total bile acids were significantly lower in 
feces of sc-inulin fed mice (1.5-fold compared to control P<0.05, Fig. 5B), while only 
a trend was observed for lc-inulin (P=0.09, Fig. 5B). Correspondingly, a trend towards 
a decrease in some fecal bile acids species was noted in sc-inulin fed mice such as for 
deoxycholic acid (DCA, P=0.07, Fig. 5C). 
Composition of bile acids in bile remained unaltered with sc- and lc-inulin feeding 
(Fig. 5D). With respect to plasma bile acids (Fig. 5E) sc-inulin fed mice showed a 
decreasing trend in the levels of chenodeoxycholic (CDCA, P=0.06), deoxycholic 
acid (DCA, P=0.06) and higher level of β-muricholic acid (β-MCA, P=0.08, Fig. 5E). 
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Figure 4: Cholesterol excretion pathways remain unaffected by dietary sc- and 
lc-inulin. (A) biliary cholesterol secretion; (B) total fecal neutral sterol (NS) excretion; 
(C)  intestinal fractional cholesterol absorption; (D) trans-intestinal cholesterol efflux 
(TICE). At day 14 bile cannulation was performed for continuous collection of bile. 
Feces were collected over 72h and analyzed for NS as detailed in methods. Fractional 
cholesterol absorption was measured using the plasma dual isotope method. Data are 
presented as box plots showing median (interquartile range) and min/max; at least n=6 
for each group. 
Lc-inulin fed mice tended to have lower levels of plasma deoxycholic acid (DCA, 
P=0.05) and higher levels β-muricholic acid (β-MCA, P=0.06, Fig. 5E). Hepatic 
mRNA gene expression of Cyp8b1, which is of major importance for the composition 
of the bile acid pool, was significantly upregulated by the lc-inulin diet (P<0.01, Fig. 
3), which, however, did not exert major effects on the bile acid pool as described above. 
On the other hand, Cyp7A1 remained largely unaffected.






























































































Figure 5: Sc- and lc-inulin induce subtle shifts in bile acid profiles. (A) Total biliary 
BA secretion; (B) total fecal BA excretion; (C) BA profile in feces; (D) Biliary BA profile 
and; (E) Plasma BA profile. At day 14 plasma, fecal and bile samples were collected 
and processed for bile acids analysis as detailed in methods. Data are presented as box 
plots showing median (interquartile range) and min/max; at least n=6 for each group. 
Statistically significant differences are indicated as *P<0.05, **P<0.01. Abbreviation: 
ω-MCA, ω-muricholic acid; β-MCA, β-muricholic acid; α-MCA, α-muricholic 
acid; CA, cholic acid; CDCA, chenodeoxy-cholic acid; LCA, lithocholic acid, DCA, 
deoxycholic acid; UDCA, ursodeoxy-cholic acid; HDCA, hyodeoxycholic acid; T-BA, 
taurine-conjugated bile acids.
Discussion
In the present study we aimed to investigate the effects of inulin on cholesterol 
homeostasis. We demonstrate that despite of substantial increase and altering in the 
ratio of microbiota-derived SCFA by sc-inulin and lc-inulin this did not translate into 
adverse effects on cholesterol metabolism. Such an assumption appeared plausible and 
thus worth investigating, since it had been shown that gut-derived acetic and butyric 
acid are incorporated into the cholesterol synthesis pathway in the liver.13 Acetic acid 
is converted into acetyl-coA, a precursor in the hepatic cholesterol synthesis pathway.22 
Butyric acid is involved in mitochondrial fatty acid oxidation eventually also yielding 
34
Interplay between dietary fibers and gut microbiota for promoting metabolic health
acetyl-coA.23 In our study, we detected increased levels of fecal acetic acid and butyric 
acid particularly with sc-inulin. However, cholesterol de novo synthesis remained 
unchanged as indicated by the comparable levels of hepatic Hmgcr mRNA expression 
among the groups and also by the fact that hepatic cholesterol concentrations remained 
unchanged. Propionic acid on the other hand, can attenuate lipid biosynthesis in 
liver.24 Elevated propionic acid in mice fed either sc- or lc- inulin, however, did not 
coincide with altered lipid levels in plasma or liver or changes in the mRNA expression 
of relevant genes for cholesterol metabolism. 
In general, with respect to plasma and liver, intestinal fermentation of fibers 
has been shown to suppress plasma and liver cholesterol as well as triglyceride 
levels.25 Here specifically the cecum has been shown to be an anatomically relevant 
location for these metabolic effects by elegant surgical intervention studies.26 These 
observations are presumably due to SCFA or other as of yet less well characterized 
bacterial products.10,27 For example, addition of propionate to hepatocytes in vitro 
was indicated to decrease cholesterol synthesis by reducing HMGCoAR activity.28,29 
The mechanism of this result has not been clearly elucidated; however, it could be 
speculated that the AMPK pathway is involved, which is on the one hand known to 
be activated by SCFA and on the other to inhibit HMGCoAR activity.28,30 Further, 
also via AMPK activation, hepatic fatty acid oxidation is increased by SCFA, while 
fatty acid synthesis is lower.10 These effects are thought to result in net improvements 
in hepatic triglyceride storage. The underlying molecular mechanisms, however, are 
still incompletely understood.
The present data also indicate that sc- and lc-inulin, despite profoundly increasing 
SCFA levels, did not affect the metabolically relevant cholesterol fluxes in the intestine. 
First, intestinal cholesterol absorption studies revealed no significant changes in 
inulin-fed animals compared to controls. Second, cholesterol excretion via the feces 
remained unaffected as well. As a consequence, intestinal excretion of cholesterol via 
the TICE pathway remained unaltered by the experimental diet. 
Cholesterol can be eliminated from the body as fecal neutral sterols and as fecal 
bile acids. Bile acids are produced as a result of metabolic conversion of cholesterol in 
the liver and are secreted into the intestine via the biliary pathway. We also analyzed 
the effects of dietary inulin on biliary secretion as well as on fecal excretion of bile 
acids. The total biliary bile acid secretion tended to increase, but significance was not 
reached. Fecal excretion of bile acids exhibited a decreasing trend potentially reflecting 
increased absorption of bile acids. In addition, subtle changes in the bile acid profiles 
were detected in plasma as well as in feces, suggesting a potential increase in absorption 
of certain bile acids species. We believe, however, that these changes are not of major 
physiological importance. 
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Microbial activity is crucial for modification of bile acid species by deconjugation 
and hydroxylation of bile acids which eventually results in the formation of secondary 
bile acids.31 No significant alterations in fecal secondary bile acid levels occurred 
indicating that at least the microbial composition with respect to bile acid metabolism 
remained unaltered upon inulin feeding. Combined, our results indicate that neither 
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